ASH News Daily 2017 - Issue 2 - B-3

Sunday, December 10, 2017

ASH News Daily

Page B-3
®

ASH Clinical Research Training Institute

he ASH Clinical Research
Training Institute (CRTI) is a
unique education and mentoring program for hematology fellows and junior faculty at academic
medical centers that offers a broad
education on clinical research methods, research collaborations, statistical analysis, and strategies for
managing the demands of family
and career. The goal of the institute
is to produce a group of researchers
armed with ideas for clinical hematology research and the tools and
access to resources to make their
ideas reality.
Dr. Brandon Blue of St. Louis
University in St. Louis, Missouri,
shared his unique experience with
the program and its participants.
Although he had spoken with former participants and faculty members about the impact of CRTI on
their careers, Dr. Blue was not sure
how the program would specifically affect his own career. "I applied to CRTI not knowing the final
impact," he recalls. "But I knew the
level of research training and networking would only have a positive outcome in my future."
Dr. Blue was in for a pleasant surprise: His fellow alums and the program faculty helped mold his career
path significantly, especially during
uncertain times. He explained that

"Future applicants and
participants of CRTI should
know the experience at
CRTI is life changing."
- Brandon Blue
fellow CRTI participants created a
"think-tank" network to share research ideas and career advice, and
to review recent literature. Dr. Blue
likens his network to a family within the larger hematology community. Each month, group members
discuss emerging breakthroughs,
bounce research ideas off each other, and find ways to support one
another's careers. The faculty members are also instrumental to the career success of participants. "CRTI
faculty continues to be involved in
my career and are available for conference calls, rapid email responses,
and in-person meet-ups."
Dr. Blue urges those considering CRTI participation to take the
plunge. "Future applicants and
participants of CRTI should know
the experience at CRTI is life changing." He mentions that the collegial
relationships one develops can continue beyond the week-long training course. While the program is
time intensive, Dr. Blue believes
that it is the most rewarding training program offered in the United

Editor
Saad Usmani, MD
Carolinas HealthCare System
Managing Editor
Juana Llorens, MS
Editorial Coordinator
Laura M. Santini, MS
Director of Communications
Jenifer Hamilton, CAE

Brandon Blue, MD

States. Dr. Blue praises the institute's one-on-one learning opportunities as well as the career advice
and mentorship provided by CRTI
faculty. "This is not the cookiecutter advice routinely given to fellows. They personalize every step
of the CRTI process to help make
your career as successful as possible."
The 2018 CRTI application cycle
is now open. Eligibility reviews
must be submitted online by 11:59
p.m. Eastern time, January 6, 2018.
To learn more, visit www.hematology.
org/CRTI.

Sunday's Continuing Conversations With the Speakers

ontinuing Conversations
with the Speakers sessions are informal discussions with scientific program
session speakers that will give
interested individuals, especially trainees and junior investigators, increased accessibility
both to information on the topic
and to the opinions of experts in
those particular fields. The dynamic nature of these sessions
is meant to provide an increased
opportunity for scientific peers
to form collaborations and partnerships. The format of these
sessions is an interactive discussion for a limited audience on a
first-come, first-served basis. Attendees should come prepared
to actively participate in the discussions.
Novel Epigenetic
Modifications in Cancer
and Development
Join Drs. Figueroa, Rao, and
Lyko to continue discussions
on mechanisms influencing epigenetic modifications. This Continuing Conversations with the
Speakers session complements

the Scientific Program session
on Novel Epigenetic Modifications in Cancer and Development and provides an increased
opportunity for scientific peers
to form collaborations and partnerships.
Sunday, December 10, 2017,
11:15 a.m. - 12:15 p.m., Georgia
World Congress Center, Building C, Level 1, C104
Chairs: Grant A. Challen,
PhD, Washington University
School of Medicine, St. Louis,
MO
Speakers: Maria E. Figueroa,
MD, University of Miami Miller
School of Medicine/Sylvester
Comprehensive Cancer Center,
Miami, FL; Anjana Rao, PhD,
La Jolla Institute for Allergy
and Immunology, La Jolla, CA;
Frank Lyko, PhD, German Cancer Research Center, Heidelberg,
Germany
Advances in Cellular
Immunotherapy for Lymphoid
Malignancies
Join Drs. Byzova, Battinelli,
and Sood to continue discus-

ASH News Daily
Staff

sions aimed at facilitating attendees understanding of complex
mechanisms
involved
platelet regulation and the role
these mechanisms play in the
development of future therapies. This Continuing Conversations with the Speakers session
complements the Scientific Program session on New Innovations in Platelet Regulation of
Tumor Growth and Metastasis
and provides an increased opportunity for scientific peers to
form collaborations and partnerships.
Sunday, December 10, 2017,
11:15 a.m. - 12:15 p.m., Georgia
World Congress Center, Building C, Level 1, C103
Chair: Michael Holinstat,
PhD, University of Michigan,
Ann Arbor, MI
Speakers: Elisabeth M. Battinelli, MD, PhD, Brigham and
Women's Hospital, Boston, MA;
Tatiana V. Byzova, PhD, Cleveland Clinic Foundation, Cleveland, OH; Anil Sood, MD, University of Texas MD Anderson
Cancer Center, Houston, TX

Production Coordinators
Tim Mercer
Jenn Waters
Deb Nerud Vernon
CustomNEWS, Inc.
Photographers
Curtis Compton
Armando Solares
CustomNEWS, Inc.
Todd Buchanan
Med Meeting Images
Advertising Representative
John Alberto
Joe Schuldner
Pharmaceutical Media, Inc.

The information contained in ASH
News Daily is provided solely for
educational purposes. A diversity
of opinions exists in the field of
hematology, and the articles in
this publication are often intended
to inform readers about more than
one point of view. These articles
are not comprehensive and should
not be used as a substitute for
traditional sources of hematology
information, traditional diagnostic
and treatment information,
or the individual judgment of
health-care providers. The views
expressed in ASH News Daily do
not necessarily represent ASH's
views, and their inclusion in
this publication should not be
interpreted as an endorsement by
ASH. ASH is not responsible for
any inaccurate or inappropriate
use of the information,
publications, products, or services
discussed or advertised within.
©2017 by the American Society of
Hematology
All materials contained in this
newspaper are protected by
copyright laws and may not be
used, reproduced, or otherwise
exploited in any manner without
the express prior permission of
ASH News Daily.
Contributing authors have
declared any financial interest
in a product or in potentially
competing products, regardless
of the dollar amount. Any such
financial interest is noted with the
author byline.

http://www.hematology.org/CRTI http://www.hematology.org/CRTI

Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 2